Migraine Marketing Wars? AbbVie, Biohaven, Eli Lilly, Amgen Lead Push for Attention in Newly Competitive Space

From: Endpoints News

By: Beth Snyder Bulik

 

For a long time, migraine sufferers were stuck with the same old medicines and advice. Try some triptans, change your diet, maybe even see if a narcotic might help — but no major drug advances to prevent or stop debilitating migraine episodes in almost 30 years…(read more)